STIVARGA
STIVARGA
Approved
DIN Number
02403390
Drug Class
Human
Market Date
Apr 2, 2013
Company
HC
Bayer Inc
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02403390
AIG Number0154134001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
L01EX05 REGORAFENIB
Product Specifications
Dosage FormTablet
Route of AdministrationOral
AHFS Classification10:00.00
Health Canada Classification
ACTIVE INGREDIENTS (1)
REGORAFENIBActive
Strength: 40 MG
Monograph: REGORAFENIB